563 U.S. 27 (2011)
Matrixx Initiatives v. Siracusano is a cornerstone securities-fraud case clarifying how courts should evaluate alleged misstatements or omissions about product safety in the absence of statistically significant data.
Must securities-fraud plaintiffs plead statistically significant evidence of a causal link between a product and adverse events to adequately allege a material misstatement or omission and scienter under §10(b) and Rule 10b-5?
There is no general duty to disclose all information; however, once an issuer speaks, it must disclose information necessary to make its statements not misleading. Materiality turns on whether there is a substantial likelihood that a reasonable investor would view the omitted or misstated information as having significantly altered the total mix of information available (Basic Inc. v. Levinson). For contingent or speculative events, materiality depends on the probability the event will occur and the magnitude of its likely impact. Under the PSLRA, a complaint must state with particularity facts giving rise to a strong inference of scienter that is cogent and at least as compelling as any opposing inference (Tellabs, Inc. v. Makor Issues & Rights, Ltd.). Statistical significance is not a prerequisite to pleading materiality or scienter.
No. The absence of statistically significant evidence does not render adverse event reports immaterial as a matter of law or preclude a strong inference of scienter. Considering the totality of the allegations, the investors adequately pleaded material misstatements or omissions and scienter. The Supreme Court affirmed the Ninth Circuit's decision allowing the claims to proceed.
Matrixx cements that materiality in securities law is a practical, investor-centered standard, not a proxy for scientific thresholds. Issuers cannot avoid liability merely by asserting that safety signals are not statistically significant if, in context, the information would be important to a reasonable investor. The case also clarifies that a duty to disclose arises when a company's voluntary statements would otherwise be misleading, and it integrates Basic's materiality standard with Tellabs's scienter pleading rule under the PSLRA. For law students, Matrixx is essential for understanding how the securities laws mediate between scientific uncertainty and investor decision-making. It is especially instructive for litigating cases involving life sciences, product safety, and other risk disclosures, and it highlights how to plead and evaluate scienter without resorting to bright-line formulas.